Company at a glance
At GenomeFrontier, our mission is to develop innovative gene therapies that are therapeutically effective and affordable, and with easy worldwide access.
CAR-T therapy has been touted as a paradigm changing gene therapy for treatment of liquid cancers. However, it is not effective against solid tumors. Using CAR-T as the first focus to demonstrate the power of our virus-free Quantum Engine™ for cell engineering, we have established Quantum CART™ (qCART™) system which is tailored specifically for engineering and production of efficacious therapies to overcome CAR-T obstacles, including those for treating solid cancers.
Seeking for talents
Our team members share a burning desire to innovate for humanity and strive towards creating a disease-free world. We cultivate an infinite mindset by promoting character-based and principle-driven way of life. We value three key qualities: passion, discipline, and principle-driven thinking. We believe that persons embodying these qualities will lead an extraordinary life, which fosters a win-win-win situation for our team member, the company and humanity as a whole.
We therefore seek talents who also possess an infinite mindset and are passionate about striving for an extraordinary life to join our team at GenomeFrontier. We believe that by combining this mindset with discipline, timeless principles, and the right state of mind, we can achieve extraordinary results and greatly impact the world for everyone.
Currently, we are looking for talents in the following areas:
1. Research Scientist - Immunologist
• PhD in immunology, molecular biology, cell biology, or related life sciences.
• Knowledge in immunology and extensive experience in antibody biology and
immune oncology studies carried out in mice.
• Expertise in independent establishment and analyses of immune cell culture
systems.
2. Research Scientist – Stem Cell Biologist
• PhD in cell biology, molecular biology, or related life sciences.
• Knowledge and extensive experience in the areas of induced pluripotent stem (iPS) cell and/or embryonic stem (ES) cell differentiation, especially in application of these knowledge in immunology.